Caplin Point Laboratories has informed that the meeting of the Board of Directors of the Company is scheduled on 12/05/2022 ,inter alia, to consider and approve Board meeting intimation to consider and approve, the annual audited financial results of the Company for the year ended 31st March 2022 (both standalone & consolidated) and declaration of Interim Dividend, if any, for the FY 2021-22 and fixation of record date for determining the eligibility of shareholders.
The above information is a part of company’s filings submitted to BSE.
